
Startup
Nectome
Y Combinator backed startup developing aldehyde-stabilized brain preservation aimed at future mind uploading.
Nobody has vouched for Nectome yet
The first person to vouch is the scout. Everyone after adds their name and their reason.
Scouted by
Nobody yet
The first person to vouch for Nectome is its scout, and that stays on the record.
Vouched by
Open. Vouches appear here in the order they were made.
Believe in Nectome? Be its scout.
One reason, in your own words. It takes about two minutes.
Vouch for NectomeWhat vouching gets you
The founders are told
You may be invited in
Who believed, and when
Each vouch on one line, from the first one to today, and how those people know the startup.
No vouches yet. The line starts on the day of the first one.
Why people vouch
Each person says how they know the startup and why they believe in it.
No reasons yet
Reasons appear here in the words of the people who gave them, scout first.
From the founders
This page has not been claimed
When the founders of Nectome claim it with a work email, their names and their reply to the people who vouched appear here. Claiming is coming soon.
More startups in Computational Consciousness
StartupBiological computing company that grows human neurons on silicon chips and sells the CL1 code-deployable biological computer.
StartupBiocomputing startup renting remote access to human brain organoid bioprocessors through its Neuroplatform.
StartupCommercial AI research lab working on machine consciousness, neuromorphic computing, and AI agent verification (VerifyAX).
StartupPublic benefit corporation pursuing whole brain emulation via AI-proofread connectomics, starting with an embodied fruit fly brain.
StartupTokyo neuroscience and AI company whose research arm builds agents based on Global Workspace Theory and studies artificial consciousness.
StartupJapanese robotics startup that markets an 'artificial consciousness' (AC) architecture giving robots curiosity and long-term memory.
What you can do with Nectome
Two of these work today. The rest are on the way.
Claim this page
Follow Nectome
Send it to an investor
Ask for an introduction
Is this page right?How the research works